Intended for healthcare professionals


Not enough evidence to justify ovarian cancer screening

BMJ 1999; 318 doi: (Published 13 March 1999) Cite this as: BMJ 1999;318:687
  1. Richard Woodman
  1. London

    Screening women for ovarian cancer should not be considered until the potential benefit, harm, and cost have been assessed in randomised clinical trials, says a report from the NHS Centre for Reviews and Dissemination.

    Dr Ruth Bell, a visiting research fellow at the centre, and her coauthors said that a systematic review of prospective screening studies showed that ultrasound screening and the serum test for CA125 could detect ovarian cancer …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription